Prescription Digital Therapeutic Market, Global Outlook and Forecast 2024-2030

The global Prescription Digital Therapeutic Market was valued at US$ 105.3 million in 2023 and is predicted to reach US$ 1.6 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 45.0% during the forecast period (2023-2030).

Prescription Digital Therapeutics (PDTs) are software-based medical treatments that are prescribed by healthcare providers to treat specific medical conditions. These treatments are designed to deliver evidence-based therapeutic interventions through devices such as smartphones, tablets, or computers. PDTs undergo rigorous clinical trials and regulatory approval, similar to traditional pharmaceutical drugs, to ensure their safety and effectiveness.

Report Sample includes:

- Table of Contents

- List of Tables & Figures

- Charts

- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-prescription-digital-therapeutic-forecast-2024-2030-373

They are used to treat a variety of conditions, including mental health disorders, substance use disorders, diabetes management, and chronic diseases. PDTs can provide real-time monitoring, personalized feedback, and support, often in conjunction with traditional therapies or medications.

The global key manufacturers of Prescription Digital Therapeutic include Better Therapeutics, BigHealth, Biofourmis, Click Therapeutics, Happify, Limbix Health, Medtronic, NuvoAir AB and Omada Health, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Prescription Digital Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Digital Therapeutic. This report contains market size and forecasts of Prescription Digital Therapeutic in global, including the following market information:

• Global Prescription Digital Therapeutic Market Revenue, 2019-2024, 2025-2030, ($ millions)

• Global top five companies in 2023 (%)

We surveyed the Prescription Digital Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prescription Digital Therapeutic Market, by Type, 2019-2024, 2025-2030 ($ millions)

Global Prescription Digital Therapeutic Market Segment Percentages, by Type, 2023 (%)

• Outpatient Treatment

• Monotherapy

Global Prescription Digital Therapeutic Market, by Application, 2019-2024, 2025-2030 ($ millions)

Global Prescription Digital Therapeutic Market Segment Percentages, by Application, 2023 (%)

• Hospitals

• Specialty Clinics

• Others

Global Prescription Digital Therapeutic Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)

Global Prescription Digital Therapeutic Market Segment Percentages, By Region and Country, 2023 (%)

• North America

• US

• Canada

• Mexico

• Europe

• Germany

• France

• U.K.

• Italy

• Russia

• Nordic Countries

• Benelux

• Rest of Europe

• Asia

• China

• Japan

• South Korea

• Southeast Asia

• India

• Rest of Asia

• South America

• Brazil

• Argentina

• Rest of South America

• Middle East & Africa

• Turkey

• Israel

• Saudi Arabia

• UAE

• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Prescription Digital Therapeutic revenues in global market, 2019-2024 (estimated), ($ millions)

• Key companies Prescription Digital Therapeutic revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Better Therapeutics

• BigHealth

• Biofourmis

• Click Therapeutics

• Happify

• Limbix Health

• Medtronic

• NuvoAir AB

• Omada Health

• Pear Therapeutics

• ResMed

• SAMSUNGHEALTHCARE

• Sensyne Health

• Solera Network

• Voluntis

• Welldocs Bluestar

• Xealth

Outline of Major Chapters:

Chapter 1: Introduces the definition of Prescription Digital Therapeutic, market overview.

Chapter 2: Global Prescription Digital Therapeutic market size in revenue.

Chapter 3: Detailed analysis of Prescription Digital Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prescription Digital Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-prescription-digital-therapeutic-forecast-2024-2030-373

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

Follow Us On linkedin :-https://www.linkedin.com/company/24-market-reports